MentionFox
Home › Executive changes › Personalis, Inc.
Leadership changes · PSNL · SEC Form 8-K, Item 5.02

Leadership changes at Personalis, Inc. (2026)

Before you join, sell to or invest in Personalis, Inc.

MentionFox check on Personalis, Inc.: only 1 source on file so far (checked 14 November 2026). Run a full check before you rely on it. mentionfox.com/c/executive-changes/personalis

Check Personalis, Inc. before you join, sell or invest Free, no sign-up: every record on file, each linked to its source.

What do you want to do about Personalis, Inc.?

Who joined and who left Personalis, Inc. (PSNL)? 1 filing reported on 2026-03-17, each cited to the company's own filing.

As of November 14, 2026, Personalis, Inc. has reported one leadership change filing to the SEC under Item 5.02 of Form 8-K, on March 17, 2026 (Form 8-K, March 17, 2026).

29 companies changed executives this week, 1 had other signals.

Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.

ONITY GROUP INC.announced the departure of its Chief Investment Officer
Adicet Bio, Inc.announced the departure of its Director
MAMMOTH ENERGY SERVICES, INC.announced the departure of its Chief Operating Officer
CERENOME, INC.named a new Director
Cohen & Co Inc.named a new Chief Executive Officer
Check one company free All companies that changed executives this week

ARK Investment Management LLC also filed stake reports on 23 other companies ↓

Sell to companies like Personalis, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

Changes1
Latest filing2026-03-17

Personalis, Inc. reported a change among its directors and officers to the SEC on Form 8-K, Item 5.02, on 2026-03-17. Every row below is cited to the filing it comes from, and this page adds each new change as Personalis, Inc. files it.

Also on the record for Personalis, Inc.

DateRecordFigureOur pageSource
November 13, 2026Stake report, Schedule 13G/A, by ARK Investment Management LLC6.67% of the class5%+ stakesSource
August 14, 2026Stake report, Schedule 13G/A, by Ameriprise Financial, Inc.5.8% of the class5%+ stakesSource
August 14, 2026Stake report, Schedule 13G/A, by Deep Track Capital, LP3.82% of the class5%+ stakesSource
July 29, 2026Stake report, Schedule 13G, by BlackRock, Inc.5.9% of the class5%+ stakesSource
July 21, 2026Stake report, Schedule 13D/A, by Tempus AI, Inc.12.6% of the class5%+ stakesSource
June 10, 2026Stake report, Schedule 13D/A, by Lightspeed Venture Partners Select IV, L.P.2% of the class5%+ stakesSource
May 12, 2026Stake report, Schedule 13G, by Deep Track Capital, LP5.51% of the class5%+ stakesSource
April 8, 2026Stake report, Schedule 13G/A, by T. Rowe Price Investment Management, Inc.4.5% of the class5%+ stakesSource
February 17, 2026Stake report, Schedule 13G, by Ameriprise Financial, Inc.7.1% of the class5%+ stakesSource
January 29, 2026Stake report, Schedule 13G/A, by Orin Hirschman3.8% of the class5%+ stakesSource
January 8, 2026Stake report, Schedule 13G, by T. Rowe Price Investment Management, Inc.12.1% of the class5%+ stakesSource
September 12, 2025Stake report, Schedule 13D/A, by Tempus AI, Inc.14.5% of the class5%+ stakesSource

Selling to them or working with them? See who runs Personalis, Inc. now and the warning signs.

Free to see. No signup.

Keep reading

More on Personalis, Inc. and the records around it.

Personalis, Inc. elsewhere on the record

Companies that share a holder

Want the whole picture on Personalis, Inc.?

Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)

A Full Report on Personalis, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Personalis, Inc. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    13 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

Timeline

FiledIn / outPersonRoleEffectiveSource
2026-03-17Reportednot named in the filing8-K, 2026-03-17
Selling to Personalis, Inc.?

New leaders reset buying decisions — get the Full Report on Personalis, Inc.: who runs it, how the money works and what to watch, every claim linked to its source.

Get the Full Report

Watch Personalis, Inc.

Hiring for a seat like this?

Find people with the same kind of experience as the senior executive at Personalis, Inc., with the record behind each one.

Find candidates like senior executive at Personalis, Inc.

Every change, in the filing's words

Filed 2026-03-17 · 8-K

Reported

On March 13, 2026, the board of directors (the "Board") of Personalis, Inc. (the "Company"), based in part on the recommendation of Christopher Hall, the Company's Chief Executive Officer, appointed Richard Chen as the Company's President, in addition to his roles as the Company's Executive Vice President, R&D, and Chief Medical Officer.

Also stated in this filing

  • Dr. Chen, age 55, has served as the Company's Executive Vice President, R&D, since March 2023 and as Chief Medical Officer since July 2021.
  • Before that, he served as the Company's Senior Vice President, R&D from July 2021 to March 2023 and Chief Scientific Officer from November 2011 to July 2021.
  • Since September 2011, Dr. Chen has served on the clinical faculty at Stanford University School of Medicine.
  • In August 1997, Dr. Chen co-founded Ingenuity Systems, a genomic data software company.
  • Dr. Chen holds a B.S. in Computer Science from Stanford University, an M.S. in Medical Informatics from Stanford University School of Medicine, and an M.D. from Stanford University School of Medicine.
  • In connection with his appointment as the Company's President, Dr. Chen's annual base salary will be increased to $570,000, effective April 1, 2026, and his performance bonus target has been increased to 70% of his then-current annual base salary.
  • The foregoing equity awards will be granted under the Company's 2019 Equity Incentive Plan.

Tools for this story

Each opens in a new tab, filled in for Personalis, Inc.. With no account yet, you sign up free and land on the result.

Where this comes from

A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.

Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.

Not for employment, credit or tenancy decisions. MentionFox research is for sales, partnership and investor research. Permitted use

Cite this page

Permanent URL: https://mentionfox.com/executive-changes/personalis
Last updated 2026-11-14
Primary record: SEC filing 1 · SEC filing 2 · SEC filing 3 · SEC filing 4
What changed at the top of Personalis, Inc.? (2026). MentionFox, 2026-11-14. https://mentionfox.com/executive-changes/personalis